Ondansetron dose for adult for gastric vomiting
Reading File
Finding Sources
Searching the Web
ondansetron adult dose nausea vomiting gastric 2024
Reading File
Here is a complete, evidence-based summary of ondansetron dosing in adults for nausea and vomiting:
Ondansetron (Zofran) - Adult Dosing for Nausea & Vomiting
Mechanism
Ondansetron is a selective 5-HT3 (serotonin) receptor antagonist that blocks receptors at the chemoreceptor trigger zone (CTZ) and vagus nerve terminals in the GI tract.
Standard Adult Doses
| Route | Dose | Frequency |
|---|---|---|
| Oral (PO) | 4-8 mg | Every 8-12 hours as needed |
| IV / IM | 4-8 mg | Every 8 hours as needed |
| IV (single dose) | Up to 16 mg | Once (non-elderly) |
By Indication
General nausea/vomiting (ED / gastric causes):
- Initial dose: 4-8 mg PO or IV - this is first-line in the emergency setting
- A single IV dose up to 16 mg is considered safe in non-elderly adults
- In elderly patients: do not exceed 8 mg, infused over at least 15 minutes
Post-operative nausea/vomiting (PONV):
- 4 mg IV given at end of surgery, or as needed post-op
Chemotherapy-induced nausea/vomiting (CINV):
- Highly emetogenic regimens: 0.15 mg/kg IV x 3 doses (max 16 mg/dose), or 24 mg PO 30 min before chemotherapy
- Moderately emetogenic: 8 mg PO twice daily for 2 days
Important Safety Notes
- QT prolongation risk - dose-dependent; check ECG in at-risk patients (prolonged QT, electrolyte imbalances)
- Correct electrolytes (K+ and Mg2+) before IV administration per FDA recommendation
- Serotonin syndrome risk if co-administered with other serotonergic drugs
- Max IV single dose: 16 mg (FDA warning - higher doses increase QT risk)
Available Formulations
- Tablets: 4 mg, 8 mg
- Orally disintegrating tablets (ODT): 4 mg, 8 mg
- Oral solution: 4 mg/5 mL
- Injection: 4 mg/2 mL (for IV or IM use)
Sources: Rosen's Emergency Medicine (10th ed.), p. 292; Goodman & Gilman's Pharmacological Basis of Therapeutics; Drugs.com monograph
Note: For gastric/GI-related vomiting specifically, metoclopramide 10-20 mg IV/IM is also a first-line option (prokinetic) - especially useful in gastroparesis or GI dysmotility.
This is a shared conversation. Sign in to Orris to start your own chat.